Want to see GB:GNIP full AI Analyst Report?
Top Page
GenIP Plc
(LSE:GNIP)
Select Model
Select Model
Rating:44Neutral
Price Target:
5.00 p
▼(-51.22% Downside)
Action:N/A
Date:06/08/26
The score is held down primarily by heavy ongoing losses and negative free cash flow despite strong revenue growth, alongside weak technical trend signals with the stock trading below major moving averages. Balance-sheet leverage improved meaningfully with debt eliminated, but valuation support is limited due to the lack of usable P/E and dividend yield data.
Positive Factors
Revenue Growth
The large year-over-year revenue increase indicates accelerating market traction and product adoption. Sustained top-line growth over multiple periods would support operating leverage, provide scale to absorb fixed costs, and create a clearer path to profitability and durable cash generation if maintained.
Negative Factors
Persistent Losses
Despite revenue gains, the business continues to report substantial operating and net losses. Deep negative margins imply that without sustained margin recovery or far greater scale, profitability is unlikely, which will continue to erode equity and constrain strategic flexibility over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The large year-over-year revenue increase indicates accelerating market traction and product adoption. Sustained top-line growth over multiple periods would support operating leverage, provide scale to absorb fixed costs, and create a clearer path to profitability and durable cash generation if maintained.
Read all positive factors
GenIP Plc (GNIP) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£1.16M
Dividend YieldN/A
Average Volume (3M)16.91K
Price to Earnings (P/E)―
Beta (1Y)1.49
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees2
SectorGeneral
Sector StrengthN/A
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding25,517,462
10 Day Avg. Volume16,560
30 Day Avg. Volume16,910
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GenIP Plc Business Overview & Revenue Model
Company Description
GenIP Plc specializes in developing pioneering generative artificial intelligence solutions. The company was founded on February 23, 2024, and its primary operations are situated in London, United Kingdom....
GenIP Plc Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
56
Neutral
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 |
|---|---|---|---|
Income Statement | |||
| Total Revenue | 0.00 | 520.39K | 123.02K |
| Gross Profit | 0.00 | 164.74K | 15.16K |
| EBITDA | -93.41K | -1.06M | -832.54K |
| Net Income | -93.56K | -1.25M | -886.83K |
Balance Sheet | |||
| Total Assets | 307.59K | 1.05M | 1.63M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 660.99K | 972.36K |
| Total Debt | 72.14K | 0.00 | 133.57K |
| Total Liabilities | 145.66K | 470.42K | 359.74K |
| Stockholders Equity | 161.93K | 579.16K | 1.27M |
Cash Flow | |||
| Free Cash Flow | -71.98K | -736.00K | -683.04K |
| Operating Cash Flow | -69.91K | -720.31K | -556.74K |
| Investing Cash Flow | -2.07K | -6.07K | -124.49K |
| Financing Cash Flow | 71.98K | 415.01K | 1.65M |
GenIP Plc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | £64.07M | 18.55 | 21.69% | ― | -3.15% | -17.89% | |
57 Neutral | £502.79M | -6.85 | -14.39% | 1.73% | 0.82% | -997.08% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | £33.37M | 11.39 | 9.86% | 2.44% | -25.62% | -20.46% | |
46 Neutral | £50.85M | -5.16 | -25.90% | ― | -1.33% | -38.06% | |
44 Neutral | £1.16M | ― | ― | ― | ― | ― |
* General Sector Average
GB:GNIP
GenIP Plc
4.55
-25.45
-84.83%
GB:PULS
Access Intelligence
36.50
-4.00
-9.88%
GB:CLBS
Celebrus Technologies
88.00
-89.38
-50.39%
GB:GBG
GB Group plc
220.50
-10.43
-4.52%
GB:IGP
Intercede
105.00
-59.50
-36.17%
GenIP Plc Corporate Events
Regulatory Filings and Compliance
GenIP Updates Total Voting Rights and Share Capital Structure
Neutral
May 29, 2026
GenIP Plc has confirmed that its total issued share capital consists of 25,517,461 ordinary shares of £0.00425 each, all carrying voting rights, and that it holds no shares in treasury. This updated share capital figure provides investors wit...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
GenIP posts rapid revenue growth as AI-driven innovation services scale globally
Positive
May 27, 2026
GenIP, which operates through its Invention Intelligence product suite and IP Commercialisation Services, provides AI-powered market intelligence reports and end-to-end innovation support to accelerate technology transfer and improve RD decision-m...
Business Operations and Strategy
GenIP lands new global university contracts as AI innovation tools gain traction
Positive
May 21, 2026
GenIP Plc has announced a series of new international orders for its AI-driven innovation evaluation services, expanding its footprint across Hong Kong, the U.K., South Africa, Canada, and the U.S. The company has signed a 12‑month framework...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
GenIP raises £350,000 in discounted share placing to fund AI-led growth
Positive
May 1, 2026
GenIP Plc, an AIM-quoted AI-driven innovation consultancy, has raised £350,000 before expenses through a discounted placing of 5,000,000 new shares at 7p each, equivalent to roughly 24.4% of its existing share capital. The funding comes as th...
Business Operations and StrategyPrivate Placements and Financing
GenIP raises £350,000 in discounted share placing to fund AI-driven growth
Positive
May 1, 2026
GenIP Plc has raised £350,000 via a placing of 5,000,000 new shares at 7p, a 38% discount to the prior close, to fund staffing, research and development, and general working capital. The move, which increases its issued share capital to 25.5 ...
Business Operations and Strategy
GenIP Strikes Strategic U.S. Alliance With Cardinal IP to Drive AI-Led Growth
Positive
Apr 28, 2026
GenIP Plc has entered a strategic resale alliance with Cardinal Intellectual Property, creating a reciprocal arrangement under which each firm will sell the other’s services and combining GenIP’s AI-driven analytics platform with Cardi...
Business Operations and StrategyFinancial Disclosures
GenIP accelerates global AI-led innovation consultancy growth with Asia surge and expanded product suite
Positive
Mar 31, 2026
GenIP reported continued rapid commercial expansion in early 2026, following roughly 330% revenue growth in FY25, with strong order intake across the U.S., Asia and other key markets and renewal discussions under way with many FY25 clients. Asia h...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.